review article | Q7318358 |
scholarly article | Q13442814 |
P50 | author | Gerard Tromp | Q37640706 |
Helena Kuivaniemi | Q42067412 | ||
P2093 | author name string | Irene Hinterseher | |
P2860 | cites work | Cutis laxa arising from frameshift mutations in exon 30 of the elastin gene (ELN) | Q22008606 |
DANCE, a novel secreted RGD protein expressed in developing, atherosclerotic, and balloon-injured arteries | Q22010449 | ||
Cystatin C deficiency in human atherosclerosis and aortic aneurysms | Q22010733 | ||
The defect in Marfan syndrome | Q22122364 | ||
Fibulin-5 is an elastin-binding protein essential for elastic fibre development in vivo | Q24292210 | ||
A genomewide exploration suggests a new candidate gene at chromosome 11q23 as the major determinant of plasma homocysteine levels: results from the GAIT project | Q24530955 | ||
Association of a G994 -->T missense mutation in the plasma platelet-activating factor acetylhydrolase gene with risk of abdominal aortic aneurysm in Japanese | Q24542068 | ||
Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival | Q24672127 | ||
Genetic analysis of MMP3, MMP9, and PAI-1 in Finnish patients with abdominal aortic or intracranial aneurysms | Q28137791 | ||
Cyclooxygenase-2 expression and inhibition in atherothrombosis | Q28165912 | ||
T-786-->C mutation in the 5'-flanking region of the endothelial nitric oxide synthase gene is associated with coronary spasm | Q28198949 | ||
Cystatin C deficiency is associated with the progression of small abdominal aortic aneurysms | Q28202574 | ||
Fibulin-5/DANCE is essential for elastogenesis in vivo | Q28216334 | ||
Homozygosity for a missense mutation in fibulin-5 (FBLN5) results in a severe form of cutis laxa | Q28218665 | ||
The influence of 4G/5G polymorphism in the plasminogen activator inhibitor-1 gene promoter on the incidence, growth and operative risk of abdominal aortic aneurysm | Q28218844 | ||
Genetic approach to the role of cysteine proteases in the expansion of abdominal aortic aneurysms | Q28238204 | ||
Aneurysm syndromes caused by mutations in the TGF-beta receptor | Q28259654 | ||
Evidence of association of the ecNOS gene polymorphism with plasma NO metabolite levels in humans | Q74424403 | ||
Abdominal aortic aneurysm: association between haptoglobin phenotypes, elastase activity, and neutrophil count in the peripheral blood | Q74533268 | ||
Matrix metalloproteinase-2 production and its binding to the matrix are increased in abdominal aortic aneurysms | Q77380951 | ||
Stromelysin-1 (matrix metalloproteinase-3) and tissue inhibitor of metalloproteinase-3 are overexpressed in the wall of abdominal aortic aneurysms | Q77559142 | ||
Alleles of the alpha-1-antitrypsin phenotype in patients with aortic aneurysms | Q77618805 | ||
Increased plasma levels of metalloproteinase-9 are associated with abdominal aortic aneurysms | Q77773046 | ||
TIMP-2 and PAI-1 mRNA levels are lower in aneurysmal as compared to athero-occlusive abdominal aortas | Q79106762 | ||
Polymorphic analysis of the matrix metalloproteinase-9 gene and susceptibility to sporadic abdominal aortic aneurysm | Q79558076 | ||
The role of human leukocyte antigen genes in the formation of abdominal aortic aneurysms | Q79828391 | ||
Xylosyltransferase I variants and their impact on abdominal aortic aneurysms | Q80758195 | ||
Enhanced abdominal aortic aneurysm in TIMP-1-deficient mice | Q81339092 | ||
Abdominal aortic aneurysm in women: prevalence, risk factors, and implications for screening | Q81370204 | ||
The interleukin-10-1082 'A' allele and abdominal aortic aneurysms | Q81370213 | ||
Genome-wide linkage in three Dutch families maps a locus for abdominal aortic aneurysms to chromosome 19q13.3. | Q81811242 | ||
Angiotensin-converting enzyme (ACE, I/D) gene polymorphism and susceptibility to abdominal aortic aneurysm or aortoiliac occlusive disease | Q81811698 | ||
C-reactive protein (CRP) elevation in patients with abdominal aortic aneurysm is independent of the most important CRP genetic polymorphism | Q82174658 | ||
Common polymorphisms of Fibulin-5 and the risk of abdominal aortic aneurysm development | Q82787981 | ||
Methylenetetrahydrofolate reductase mutation in subjects with abdominal aortic aneurysm subdivided for age | Q83154543 | ||
The influence of COX-2 single nucleotide polymorphisms on abdominal aortic aneurysm development and the associated inflammation | Q84277404 | ||
Is there an association between angiotensin converting enzyme (ACE) genotypes and abdominal aortic aneurysm? | Q84590940 | ||
Human leukocyte antigen class II immune response genes, female gender, and cigarette smoking as risk and modulating factors in abdominal aortic aneurysms | Q74139397 | ||
Acute phase reactants in patients with abdominal aortic aneurysm | Q74252599 | ||
Association of a variable number of tandem repeats in the endothelial constitutive nitric oxide synthase gene with essential hypertension in Japanese | Q74318376 | ||
Involvement of polymorphisms in the chemokine system in the susceptibility for coronary artery disease (CAD). Coincidence of elevated Lp(a) and MCP-1 -2518 G/G genotype in CAD patients | Q74354815 | ||
Cytokine pattern in aneurysmal and occlusive disease of the aorta | Q43816879 | ||
Differential regulation of matrix metalloproteinase activities in abdominal aortic aneurysms | Q43904927 | ||
A polymorphism in the cyclooxygenase 2 gene as an inherited protective factor against myocardial infarction and stroke | Q44103563 | ||
The Glu298Asp polymorphism of the NOS 3 gene as a determinant of the baseline production of nitric oxide | Q44164789 | ||
Increased risk of the abdominal aortic aneurysm in carriers of the MTHFR 677T allele | Q44318046 | ||
Missense variations in the fibulin 5 gene and age-related macular degeneration | Q28273364 | ||
Overlapping and differential expression of BIG-2, BIG-1, TAG-1, and F3: four members of an axon-associated cell adhesion molecule subgroup of the immunoglobulin superfamily | Q28274972 | ||
Genomewide association studies and assessment of the risk of disease | Q28288414 | ||
Fibulin-2 exhibits high degree of variability, but no structural changes concordant with abdominal aortic aneurysms | Q28293755 | ||
Direct evidence for the importance of endothelium-derived nitric oxide in vascular remodeling | Q28592810 | ||
Genome-wide association study identifies a sequence variant within the DAB2IP gene conferring susceptibility to abdominal aortic aneurysm | Q28943557 | ||
Chemokines and leukocyte traffic | Q29618886 | ||
A common variant of endothelial nitric oxide synthase (Glu298Asp) is an independent risk factor for carotid atherosclerosis. | Q32137397 | ||
Evidence for association between the HLA-DQA locus and abdominal aortic aneurysms in the Belgian population: a case control study | Q33252377 | ||
Angiotensin-converting enzyme inhibitors and aortic rupture: a population-based case-control study | Q33254545 | ||
Whole genome expression profiling reveals a significant role for immune function in human abdominal aortic aneurysms | Q33290991 | ||
Analysis of tissue inhibitor of metalloproteinase-2 gene polymorphisms in a caucasian population with abdominal aortic aneurysms | Q33360012 | ||
Association of PPARgamma allelic variation, osteoprotegerin and abdominal aortic aneurysm | Q33575645 | ||
Apolipoprotein E genotype is associated with serum C-reactive protein but not abdominal aortic aneurysm | Q33756098 | ||
Altered vascular remodeling in fibulin-5-deficient mice reveals a role of fibulin-5 in smooth muscle cell proliferation and migration | Q33863783 | ||
Diabetes and the abdominal aortic aneurysm | Q34020340 | ||
Polymorphisms within the C-reactive protein (CRP) promoter region are associated with plasma CRP levels | Q34021076 | ||
Genetic analysis of polymorphisms in biologically relevant candidate genes in patients with abdominal aortic aneurysms | Q34074796 | ||
Osteopontin: a key cytokine in cell-mediated and granulomatous inflammation | Q34216288 | ||
Familial abdominal aortic aneurysms | Q34241293 | ||
An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels | Q34262228 | ||
A mutation in the gene for type III procollagen (COL3A1) in a family with aortic aneurysms | Q34262977 | ||
Pathogenesis of abdominal aortic aneurysm | Q34323112 | ||
Sequence variant on 9p21 is associated with the presence of abdominal aortic aneurysm disease but does not have an impact on aneurysmal expansion | Q34325894 | ||
Association of the TGF-beta receptor genes with abdominal aortic aneurysm. | Q34328497 | ||
The lifetime prevalence of abdominal aortic aneurysms among siblings of aneurysm patients is eightfold higher than among siblings of spouses: an analysis of 187 aneurysm families in Nova Scotia, Canada | Q34374641 | ||
Aortic aneurysms: an immune disease with a strong genetic component | Q34402629 | ||
Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice | Q34433103 | ||
Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction | Q34545496 | ||
Abdominal aortic aneurysms: basic mechanisms and clinical implications | Q34555454 | ||
Linkage of Marfan syndrome and a phenotypically related disorder to two different fibrillin genes | Q34592768 | ||
Sequencing of cDNA from 50 unrelated patients reveals that mutations in the triple-helical domain of type III procollagen are an infrequent cause of aortic aneurysms | Q34731356 | ||
Binding sites for ETS family of transcription factors dominate the promoter regions of differentially expressed genes in abdominal aortic aneurysms | Q34950585 | ||
Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels | Q35196218 | ||
Short leukocyte telomere length is associated with abdominal aortic aneurysm (AAA). | Q44528927 | ||
Genetic linkage of candidate genes in families with abdominal aortic aneurysms? | Q44549103 | ||
Human vascular smooth muscle cells possess functional CCR5. | Q44837410 | ||
Osteoprotegerin and osteopontin are expressed at high concentrations within symptomatic carotid atherosclerosis | Q44895972 | ||
Clinical and genetic associations in Marfan syndrome and related disorders | Q44919578 | ||
ACE inhibitors increase type III collagen synthesis: a potential explanation for reduction in acute vascular events by ACE inhibitors | Q44920961 | ||
A common insertion/deletion polymorphism of the thymidylate synthase (TYMS) gene is a determinant of red blood cell folate and homocysteine concentrations | Q45245204 | ||
Allelic genes involved in artery compliance and susceptibility to sporadic abdominal aortic aneurysm | Q45255546 | ||
The aneurysm detection and management study screening program: validation cohort and final results. Aneurysm Detection and Management Veterans Affairs Cooperative Study Investigators | Q45334593 | ||
The pathophysiology of abdominal aortic aneurysm growth: corresponding and discordant inflammatory and proteolytic processes in abdominal aortic and popliteal artery aneurysms | Q45391624 | ||
Interaction between angiotensin II, osteoprotegerin, and peroxisome proliferator-activated receptor-gamma in abdominal aortic aneurysm | Q46309412 | ||
The normotensive carriers of the MTHFR 677T allele, displaying the increased risk of development of the abdominal aortic aneurysm (AAA), occur at the highest frequency among the smoking patients | Q46407260 | ||
Genetic analysis of 56 polymorphisms in 17 genes involved in methionine metabolism in patients with abdominal aortic aneurysm | Q46477558 | ||
Association of osteoprotegerin with human abdominal aortic aneurysm progression | Q46531394 | ||
The methylenetetrahydrofolate reductase C677T polymorphism does not associate with susceptibility to abdominal aortic aneurysm | Q46582385 | ||
The different genotypes of MTHFR 1298A>C and PON1 -108C>T polymorphisms confer the increased risk of the abdominal aortic aneurysm in the smoking and nonsmoking persons | Q46979050 | ||
The role of the CCR5 Delta32 polymorphism in abdominal aortic aneurysms | Q47708115 | ||
Possible association between genetic polymorphisms in transforming growth factor beta receptors, serum transforming growth factor beta1 concentration and abdominal aortic aneurysm. | Q47822384 | ||
An investigation of polymorphism in the interleukin-10 gene promoter | Q48054541 | ||
Characterization of a dinucleotide repeat in the 92 kDa type IV collagenase gene (CLG4B), localization of CLG4B to chromosome 20 and the role of CLG4B in aortic aneurysmal disease | Q48076276 | ||
An increased frequency of the 5A allele in the promoter region of the MMP3 gene is associated with abdominal aortic aneurysms. | Q50665090 | ||
Does the angiotensin-converting enzyme (ACE) gene polymorphism affect rate of abdominal aortic aneurysm expansion? | Q50698692 | ||
Genetic variation on chromosome 16 is associated with abdominal aortic aneurysm. | Q50704621 | ||
Genetic risk factor for abdominal aortic aneurysm: HLA-DR2(15), a Japanese study. | Q50895981 | ||
Elevated circulating levels of inflammatory cytokines in patients with abdominal aortic aneurysm. | Q50917495 | ||
Risk factors for abdominal aortic aneurysms in older adults enrolled in The Cardiovascular Health Study. | Q51024492 | ||
Haptoglobin 2-1 phenotype predicts rapid growth of abdominal aortic aneurysms. | Q51147244 | ||
Low vitamin B6, and not plasma homocysteine concentration, as risk factor for abdominal aortic aneurysm: a retrospective case-control study. | Q51474120 | ||
Apolipoprotein E genotype is associated with differential expansion rates of small abdominal aortic aneurysms. | Q51555865 | ||
Hemizygosity at the elastin locus in a developmental disorder, Williams syndrome. | Q52223418 | ||
Molecular defects of type III procollagen in Ehlers-Danlos syndrome type IV. | Q52828944 | ||
Analysis of sequence variations in the ABCC6 gene among patients with abdominal aortic aneurysm and pseudoxanthoma elasticum. | Q53845892 | ||
eNOS G894T polymorphism and abdominal aortic aneurysms. | Q54471596 | ||
ACE DD genotype: a predisposing factor for abdominal aortic aneurysm. | Q54682070 | ||
Identification of a genetic variant associated with abdominal aortic aneurysms on chromosome 3p12.3 by genome wide association. | Q55051941 | ||
Contrasting Genetic Influence of CCR2 and CCR5 Variants on HIV-1 Infection and Disease Progression | Q56607621 | ||
The same sequence variant on 9p21 associates with myocardial infarction, abdominal aortic aneurysm and intracranial aneurysm | Q56891289 | ||
Genes Predisposing to Rapid Aneurysm Growth | Q56891358 | ||
Genotype-phenotype relationships in an investigation of the role of proteases in abdominal aortic aneurysm expansion | Q56891425 | ||
Influence of type III collagen genotype on aortic diameter and disease | Q56891769 | ||
Selection for screening for familial aortic aneurysms | Q56891849 | ||
Genetic variants of collagen III and abdominal aortic aneurysm | Q56891862 | ||
Association Study of Single Nucleotide Polymorphisms on Chromosome 19q13 With Abdominal Aortic Aneurysm | Q56893394 | ||
The Intracranial Aneurysm Susceptibility Genes HSPG2 and CSPG2 Are Not Associated With Abdominal Aortic Aneurysm | Q56893407 | ||
Matrix Metalloproteinase-2 Gene Variants and Abdominal Aortic Aneurysm | Q57253631 | ||
Polymorphisms of the Interleukin-6 Gene Promoter and Abdominal Aortic Aneurysm | Q57253671 | ||
Association Between Osteopontin and Human Abdominal Aortic Aneurysm | Q57253686 | ||
Functional Polymorphism in the Regulatory Region of Gelatinase B Gene in Relation to Severity of Coronary Atherosclerosis | Q57279243 | ||
Assessment of the association between genetic polymorphisms in transforming growth factor beta, and its binding protein (LTBP), and the presence, and expansion, of Abdominal Aortic Aneurysm | Q57316566 | ||
Inheritance of an RNA splicing mutation (G+ 1 IVS20) in the type III procollagen gene (COL3A1) in a family having aortic aneurysms and easy bruisability: phenotypic overlap between familial arterial aneurysms and Ehlers-Danlos syndrome type IV. | Q35198203 | ||
Polymorphisms in genes involved in folate metabolism and colorectal neoplasia: a HuGE review | Q35672899 | ||
Fibulins in development and heritable disease | Q35726742 | ||
Cellular localization of the chemokine receptor CCR5. Correlation to cellular targets of HIV-1 infection. | Q35764050 | ||
Expression of heme oxygenase-1 in atherosclerotic lesions | Q35765057 | ||
Role of hyperhomocysteinemia in aortic disease. | Q36037038 | ||
Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation | Q36082965 | ||
A human vascular disorder, supravalvular aortic stenosis, maps to chromosome 7. | Q36228410 | ||
C-reactive protein is produced by a small number of normal human peripheral blood lymphocytes | Q36352119 | ||
Angiotensin II-accelerated atherosclerosis and aneurysm formation is attenuated in osteopontin-deficient mice | Q36524275 | ||
Postoperative incision hernia in patients with abdominal aortic aneurysm and aortoiliac occlusive disease: a systematic review | Q36578175 | ||
Candidate gene association studies in abdominal aortic aneurysm disease: a review and meta-analysis. | Q36962843 | ||
Expression of the elastolytic cathepsins S and K in human atheroma and regulation of their production in smooth muscle cells | Q37384330 | ||
Inherited diseases and syndromes leading to aortic aneurysms and dissections | Q37398308 | ||
Angiotensin II type 1 receptor 1166C polymorphism is associated with abdominal aortic aneurysm in three independent cohorts | Q37415982 | ||
Developments in genomics to improve understanding, diagnosis and management of aneurysms and peripheral artery disease. | Q37603957 | ||
SVS practice guidelines for the care of patients with an abdominal aortic aneurysm: executive summary | Q37604608 | ||
Sp1 increases expression of cyclooxygenase-2 in hypoxic vascular endothelium. Implications for the mechanisms of aortic aneurysm and heart failure | Q38311997 | ||
Gene expression profiling of peripheral blood in patients with abdominal aortic aneurysm | Q38510939 | ||
Whole genome-expression profiling reveals a role for immune and inflammatory response in abdominal aortic aneurysm rupture. | Q38511431 | ||
Microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with susceptibility to emphysema | Q39818948 | ||
Novel genetic mechanisms for aortic aneurysms | Q39876021 | ||
ACE and TGFBR1 genes interact in influencing the susceptibility to abdominal aortic aneurysm | Q40081802 | ||
A 6 bp polymorphism in the thymidylate synthase gene causes message instability and is associated with decreased intratumoral TS mRNA levels | Q40561489 | ||
Racial differences in the incidence of femoral bypass and abdominal aortic aneurysmectomy in Massachusetts: relationship to cardiovascular risk factors. | Q40604544 | ||
Identification of genetic variation that determines levels of plasma triglycerides and hypercoagulability | Q40648445 | ||
Interleukin-6 (IL-6) and the prognosis of abdominal aortic aneurysms | Q40706826 | ||
Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway | Q40890343 | ||
Polymorphisms of the matrix metalloproteinase 9 gene and abdominal aortic aneurysm | Q41148674 | ||
Local expression of inflammatory cytokines in human atherosclerotic plaques | Q41531228 | ||
ECM and cell surface proteolysis: regulating cellular ecology | Q41656253 | ||
Transcriptional regulation through cytokine and glucocorticoid response elements of rat acute phase plasma protein genes by C/EBP and JunB | Q41660299 | ||
Epidemiology of aortic aneurysm repair in the United States from 1993 to 2003. | Q42607112 | ||
Genetic and environmental contributions to abdominal aortic aneurysm development in a twin population | Q42640800 | ||
Human abdominal aortic aneurysms. Immunophenotypic analysis suggesting an immune-mediated response | Q42773864 | ||
Genome Wide Association Studies: identifying the genes that determine the risk of abdominal aortic aneurysm | Q43111346 | ||
The genetics of abdominal aortic aneurysms: a comprehensive meta-analysis involving eight candidate genes in over 16,700 patients | Q43123918 | ||
Overexpression of functionally coupled cyclooxygenase-2 and prostaglandin E synthase in symptomatic atherosclerotic plaques as a basis of prostaglandin E(2)-dependent plaque instability | Q43714032 | ||
Matrix metalloproteinase 2 polymorphisms in a caucasian population with abdominal aortic aneurysm | Q43805798 | ||
Regarding “Identification of a genetic variant associated with abdominal aortic aneurysms on chromosome 3p12.3 by genome wide association” | Q57445681 | ||
Functional matrix metalloproteinase-9 polymorphism (C-1562T) associated with abdominal aortic aneurysm | Q57445690 | ||
HLA-DQA Is Associated with Abdominal Aortic Aneurysms in the Belgian Population | Q57783954 | ||
Genome Scan for Familial Abdominal Aortic Aneurysm Using Sex and Family History as Covariates Suggests Genetic Heterogeneity and Identifies Linkage to Chromosome 19q13 | Q57783968 | ||
Analysis of coding sequences for tissue inhibitor of metalloproteinases 1 (TIMP1) and 2 (TIMP2) in patients with aneurysms | Q57783985 | ||
Multiple Defects in Type III Collagen Synthesis Are Associated with the Pathogenesis of Abdominal Aortic Aneurysms | Q57784050 | ||
Deletion Polymorphism in the Gene for Angiotensin-converting Enzyme is not a Risk Factor Predisposing to Abdominal Aortic Aneurysm | Q58363877 | ||
Interleukin-1 gene cluster variants and abdominal aortic aneurysms | Q58957922 | ||
Heme oxygenase-1 gene promoter polymorphism is associated with abdominal aortic aneurysm | Q58959100 | ||
eNOS G894T polymorphism as a mild predisposing factor for abdominal aortic aneurysm | Q59402976 | ||
The cholesteryl ester transfer protein (CETP) locus as a candidate gene in abdominal aortic aneurysm | Q60440934 | ||
High prevalence of mild hyperhomocysteinemia in patients with abdominal aortic aneurysm | Q61480581 | ||
Tissue Inhibitor of Metalloproteinase-1 (TIMP-1) Polymorphisms in a Caucasian Population with Abdominal Aortic Aneurysm | Q61773589 | ||
Genetic risk factor characterizes abdominal aortic aneurysm from arterial occlusive disease in human beings: CCR5 Δ32 deletion | Q61820515 | ||
High levels of homocysteine, lipoprotein (a) and plasminogen activator inhibitor-1 are present in patients with abdominal aortic aneurysm | Q62607045 | ||
Apolipoprotein E polymorphism and atherosclerosis | Q68126635 | ||
Acute phase proteins in patients with abdominal aortic aneurysms | Q69005397 | ||
Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium | Q69908131 | ||
Decreased tissue inhibitor of metalloproteinases (TIMP) in abdominal aortic aneurysm tissue: a preliminary report | Q70191804 | ||
Elastolytic and collagenolytic studies of arteries. Implications for the mechanical properties of aneurysms | Q70195438 | ||
Blood groups and HLA antigens in patients with abdominal aortic aneurysms | Q70484833 | ||
Association between haptoglobin groups and aortic abdominal aneurysms | Q70588783 | ||
Apoptosis of vascular smooth muscle cells induced by in vitro stimulation with interferon-gamma, tumor necrosis factor-alpha, and interleukin-1 beta | Q70865443 | ||
A smoking-dependent risk of coronary artery disease associated with a polymorphism of the endothelial nitric oxide synthase gene | Q70908032 | ||
Alpha-1-antitrypsin deficiency in aneurysmal disease | Q71150753 | ||
Activated forms of MMP2 and MMP9 in abdominal aortic aneurysms | Q71218618 | ||
Quantitative studies on the inherited variants of serum alpha-1-antitrypsin | Q71269100 | ||
Unravelling the familial tendency to aneurysmal disease: popliteal aneurysm, hypertension and fibrillin genotype | Q71407507 | ||
Inflammation and matrix metalloproteinases in the enlarging abdominal aortic aneurysm | Q71938798 | ||
In situ localization and quantification of seventy-two-kilodalton type IV collagenase in aneurysmal, occlusive, and normal aorta | Q72057993 | ||
Interleukin-1 beta induces differential gene expression in aortic smooth muscle cells | Q72820997 | ||
Expression and sequence of the gene for tissue inhibitor of metalloproteinases in patients with abdominal aortic aneurysms | Q72877288 | ||
Elevations of tissue-type plasminogen activator and differential expression of urokinase-type plasminogen activator in diseased aorta | Q73025879 | ||
A common variant of the endothelial nitric oxide synthase (Glu298-->Asp) is a major risk factor for coronary artery disease in the UK | Q73049822 | ||
Genetic risk factors in inflammatory abdominal aortic aneurysms: polymorphic residue 70 in the HLA-DR B1 gene as a key genetic element | Q73114784 | ||
Negative genetic risk factor for abdominal aortic aneurysm: HLA-DQ3, a Japanese study | Q73153370 | ||
The role of cytokine gene polymorphisms in the pathogenesis of abdominal aortic aneurysms: a case-control study | Q73413687 | ||
Homocysteine induces synthesis of a serine elastase in arterial smooth muscle cells from multi-organ donors | Q73529910 | ||
Expression of matrix metalloproteinases and their inhibitors in aneurysms and normal aorta | Q73676314 | ||
Association of the 4G/5G polymorphism in the promoter region of plasminogen activator inhibitor-1 with abdominal aortic aneurysms | Q73777093 | ||
Inflammation, metalloproteinases, and increased proteolysis: an emerging pathophysiological paradigm in aortic aneurysm | Q73804291 | ||
Role of HLA-DR in the pathogenesis of abdominal aortic aneurysm | Q73807413 | ||
Genetic analysis on HLA loci in Japanese patients with abdominal aortic aneurysm | Q73807415 | ||
Abdominal aortic aneurysm in normotensive patients: association with angiotensin-converting enzyme gene polymorphism | Q73880919 | ||
Allele frequency of human endothelial nitric oxide synthase gene polymorphism in abdominal aortic aneurysm | Q73975277 | ||
Genetic similarity in inflammatory and degenerative abdominal aortic aneurysms: a study of human leukocyte antigen class II disease risk genes | Q74131947 | ||
Abdominal aortic aneurysm in women | Q74131996 | ||
P433 | issue | 3 | |
P304 | page(s) | 388-412 | |
P577 | publication date | 2010-12-13 | |
P1433 | published in | Annals of Vascular Surgery | Q15751634 |
P1476 | title | Genes and abdominal aortic aneurysm | |
P478 | volume | 25 |
Q33688781 | A balanced translocation truncates Neurotrimin in a family with intracranial and thoracic aortic aneurysm |
Q58600369 | Abdominal aortic aneurysms |
Q38592117 | An update on the etiology of abdominal aortic aneurysms: implications for future diagnostic testing |
Q33797335 | Analysis of positional candidate genes in the AAA1 susceptibility locus for abdominal aortic aneurysms on chromosome 19. |
Q50052994 | Association of SNPs in the TIMP-2 gene and large artery atherosclerotic stroke in southern Chinese Han population. |
Q37701906 | Association of non-synonymous variants in WIPF3 and LIPA genes with abdominal aortic aneurysm: an autopsy study |
Q38099097 | Associations between the insertion/deletion polymorphism of the angiotensin-converting enzyme and susceptibility to aortic aneurysms: A meta-analysis |
Q38678102 | Atherosclerosis and aortic aneurysm - is inflammation a common denominator? |
Q45954369 | Detection of Pathological Changes in the Aorta during Thoracic Aortic Aneurysm Progression on Molecular Level. |
Q41772435 | Differentially expressed genes and canonical pathways in the ascending thoracic aortic aneurysm - The Tampere Vascular Study |
Q88313529 | Expression profile of long non-coding RNAs during the differentiation of human umbilical cord derived mesenchymal stem cells into cardiomyocyte-like cells |
Q33849115 | Family members of patients with abdominal aortic aneurysms are at increased risk for aneurysms: analysis of 618 probands and their families from the Liège AAA Family Study |
Q44368997 | GT microsatellite repeats in the heme oxygenase-1 gene promoter associated with abdominal aortic aneurysm in Croatian patients |
Q39100045 | Genetic and Epigenetic Regulation of Aortic Aneurysms |
Q26828019 | Genetics of thoracic aortic aneurysm: at the crossroad of transforming growth factor-β signaling and vascular smooth muscle cell contractility |
Q35760197 | Genomic insights into abdominal aortic aneurysms |
Q36592542 | Identification of key genes associated with the human abdominal aortic aneurysm based on the gene expression profile |
Q58886358 | Lipoprotein(a) Levels in Patients With Abdominal Aortic Aneurysm |
Q34306549 | MicroRNA expression signature in human abdominal aortic aneurysms |
Q42109958 | Neutrophil Proteases Promote Experimental Abdominal Aortic Aneurysm via Extracellular Trap Release and Plasmacytoid Dendritic Cell Activation |
Q30393291 | New Insights Into Aortic Diseases: A Report From the Third International Meeting on Aortic Diseases (IMAD3) |
Q35238664 | Non coding RNAs in aortic aneurysmal disease |
Q34727936 | Population risk factor estimates for abdominal aortic aneurysm from electronic medical records: a case control study |
Q43521221 | Regional variation in the incidence of abdominal aortic aneurysm in Sweden |
Q38118275 | The association of genetic variants of matrix metalloproteinases with abdominal aortic aneurysm: a systematic review and meta-analysis |
Q38583904 | The genetic architecture of non-syndromic thoracic aortic aneurysm |
Q38212988 | The genetic basis for aortic aneurysmal disease. |
Q35723702 | The potential role of DNA methylation in abdominal aortic aneurysms |
Q65950306 | Type III collagen (COL3A1): Gene and protein structure, tissue distribution, and associated diseases. |
Q26797277 | Understanding the pathogenesis of abdominal aortic aneurysms |
Q33562974 | Update on abdominal aortic aneurysm research: from clinical to genetic studies |
Q92626176 | Y chromosome loss is associated with age-related male patients with abdominal aortic aneurysms |
Search more.